<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36846561</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2633-6960</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Oxford open immunology</Title><ISOAbbreviation>Oxf Open Immunol</ISOAbbreviation></Journal><ArticleTitle>Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity.</ArticleTitle><Pagination><StartPage>iqac006</StartPage><MedlinePgn>iqac006</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">iqac006</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/oxfimm/iqac006</ELocationID><Abstract><AbstractText>The pandemic coronavirus disease 2019 (COVID-19) can cause multi-systemic symptoms that can persist beyond the acute symptomatic phase. The post-acute sequelae of COVID-19 (PASC), also referred to as long COVID, describe the persistence of symptoms and/or long-term complications beyond 4 weeks from the onset of the acute symptoms and are estimated to affect at least 20% of the individuals infected with SARS-CoV-2 regardless of their acute disease severity. The multi-faceted clinical picture of long COVID encompasses a plethora of undulating clinical manifestations impacting various body systems such as fatigue, headache, attention disorder, hair loss and exercise intolerance. The physiological response to exercise testing is characterized by a reduced aerobic capacity, cardiocirculatory limitations, dysfunctional breathing patterns and an impaired ability to extract and use oxygen. Still, to this day, the causative pathophysiological mechanisms of long COVID remain to be elucidated, with long-term organ damage, immune system dysregulation and endotheliopathy being among the hypotheses discussed. Likewise, there is still a paucity of treatment options and evidence-based strategies for the management of the symptoms. In sum, this review explores different aspects of long COVID and maps the literature on what is known about its clinical manifestations, potential pathophysiological mechanisms, and treatment options.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haunhorst</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4819-3513</Identifier><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena 07749, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Movement Science, University of M&#xfc;nster, M&#xfc;nster 48149, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>Wilhelm</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne 50933, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Movement Science, University of M&#xfc;nster, M&#xfc;nster 48149, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellert</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department for Vascular Surgery, Lahn-Dill Clinics Wetzlar, Wetzlar 35578, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kr&#xfc;ger</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Sports Therapy, Institute of Sports Science, Justus-Liebig-University Giessen, Giessen 35394, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilser</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Hospital for Pediatrics and Adolescent Medicine, Jena University Hospital, Jena 07747, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Jena 07747, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuken</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7696-475X</Identifier><AffiliationInfo><Affiliation>Clinic for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena 07747, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pletz</LastName><ForeName>Mathias W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena 07747, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallmach</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena 07747, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena 07749, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Interdisciplinary Prevention of Diseases related to Professional Activities, Jena 07749, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oxf Open Immunol</MedlineTA><NlmUniqueID>101770669</NlmUniqueID><ISSNLinking>2633-6960</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">exercise</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-term symptoms</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">post-acute sequelae</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>27</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36846561</ArticleId><ArticleId IdType="pmc">PMC9494493</ArticleId><ArticleId IdType="doi">10.1093/oxfimm/iqac006</ArticleId><ArticleId IdType="pii">iqac006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L. et al. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescure F-X, Bouadma L, Nguyen D. et al. Clinical and virological data of the first cases of COVID-19 in Europe: A case series. Lancet Infect Dis 2020;20:697&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156120</ArticleId><ArticleId IdType="pubmed">32224310</ArticleId></ArticleIdList></Reference><Reference><Citation>White-Dzuro G, Gibson LE, Zazzeron L. et al. Multisystem effects of COVID-19: A concise review for practitioners. Postgrad Med 2020;133:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7651182</ArticleId><ArticleId IdType="pubmed">32921198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New Engl J Med 2020;383:120&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Florencio LL, G&#xf3;mez-Mayordomo V. et al. Proposed integrative model for post-COVID symptoms. Diabetes Metab Syndr Clin Res Rev 2021;15:102159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="pubmed">34186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The road to addressing long Covid. Science 2021;373:491&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E.. How and why patients made long Covid. Soc Sci Med 2020;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Boyton RJ.. Decoding the unknowns in long covid. BMJ 2021;372:n132.</Citation><ArticleIdList><ArticleId IdType="pubmed">33541867</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med 2021;27:28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L. et al. Long-COVID: An evolving problem with an extensive impact. S Afr Med J 2020;111:10&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-haul COVID. Neurology 2020;95. 10.1212/WNL.0000000000010640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C. et al. Management of post-acute covid-19 in primary care. BMJ 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. National Institute for Health and Care Excellence, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB.. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021;12:698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Martimbianco ALC, Pacheco RL, Bagattini &#xc2;M. et al. Frequency, signs and symptoms, and criteria adopted for long COVID: A systematic review. Int J Clin Pract 2021;75:e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Pavli A, Tsakris A.. Post-COVID syndrome: An insight on its pathogenesis. Nato Adv Sci Inst Se 2021;9:497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect Dis 2021;53:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kampen JJA, van de Vijver DAMC, Fraaij PLA. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun 2021;12:267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O&#x2019;Sullivan O, Senaratne KPP. et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sport Med 2020;54:949&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT.. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection. JAMA 2020;324:2251&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V. et al. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int J Environ Res Pu 2021;18:2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC. et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2021;22:S1473-3099:00703-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T. et al. Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz RF, Waller MD, Perrin F. et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res 2021;7:00655&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. et al. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X. et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 2021;398:747&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D, Bai F, Castoldi R. et al. Anxiety and depression symptoms after virological clearance of COVID&#x2010;19: A cross&#x2010;sectional study in Milan, Italy. J Med Virol 2021;93:1175&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Baricich A, Patrucco F. et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep 2021;11:22666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8608998</ArticleId><ArticleId IdType="pubmed">34811387</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Meli G, Poletti F. et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM Int J Med 2021;114:hcab297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research. Living with Covid-19&#x2014;second review. 2021. 10.3310/themedreview_45225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_45225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Barrett KMS, Riffle S. et al. Long-term COVID-19 symptoms in a large unselected population. Medrxiv2020:2020.10.07.20208702.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L. et al. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J Infect Dis 2022:jiac136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications, 2020.</Citation></Reference><Reference><Citation>Office for National Statistics. Coronavirus and the social impacts of &#x2018;long COVID&#x2019; on people&#x2019;s lives in Great Britain: 7 April to 13 June 2021, 2021.</Citation></Reference><Reference><Citation>Briggs A, Vassall A.. Count the cost of disability caused by COVID-19. Nature 2021;593:502&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34040204</ArticleId></ArticleIdList></Reference><Reference><Citation>Palstam A, Westerlind E, Sunnerhagen KS. et al. Recurrent sick leave after COVID-19: investigating the first wave of the pandemic in a comprehensive Swedish registry-based study. BMC Public Health 2021;21:1914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530010</ArticleId><ArticleId IdType="pubmed">34674673</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J. et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open 2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS. et al. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J Infection 2021;83:1&#x2013;16. 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei M, Bose D, Nouri&#x2010;Vaskeh M. et al. Long&#x2010;term side effects and lingering symptoms post COVID&#x2010;19 recovery. Rev Med Virol 2021;32:e2289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646420</ArticleId><ArticleId IdType="pubmed">34499784</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvvari TK, Kutikuppala LVS, Tsagkaris C. et al. Post&#x2010;COVID&#x2010;19 complications: Multisystemic approach. J Med Virol 2021;93. doi:10.1002/jmv.27222</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27222</ArticleId><ArticleId IdType="pmc">PMC8427008</ArticleId><ArticleId IdType="pubmed">34289162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshijima H, Mihara T, Seki H. et al. Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A living systematic review and meta-analysis. Medrxiv2021:2021.04.08.21255109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10686440</ArticleId><ArticleId IdType="pubmed">38019841</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V. et al. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. eClinicalMedicine 2021;36:100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallmach A, Kesselmeier M, Bauer M. et al. Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: Is there a specific constellation? Infection 2022;50:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741139</ArticleId><ArticleId IdType="pubmed">34997542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudziol H, Kirschstein T, Pletz MW. et al. High prevalence of long-term olfactory dysfunction confirmed by olfactory testing after a community COVID-19 outbreak. HNO 2022;70:224&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8697538</ArticleId><ArticleId IdType="pubmed">34940903</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V. et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med 2021;92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon D, Slama D, Broucker TD. et al. Clinical, virological and imaging profile in patients with persistent or resurgent forms of COVID-19: A cross-sectional study. J Infect 2020;82:e1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME. et al. Characteristics and impact of long Covid: Findings from an online survey. PLoS ONE 2022;17:e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Pallar&#xe9;s JG, Buend&#xed;a-Romero &#xc1;. et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Pub Health 2021;18:5329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M. et al. Surviving COVID-19 in Bergamo province: A post-acute outpatient re-evaluation. Epidemiol Infect 2021;149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Ausserhofer D. et al. Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey. Clin Infect Dis 2021;75:ciab978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022;13:1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavi L. Postural tachycardia syndrome and long COVID: An update. Br J Gen Pract 2022;72:8&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714530</ArticleId><ArticleId IdType="pubmed">34972793</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A. et al. Long-COVID postural tachycardia syndrome: An American Autonomic Society statement. Clin Auton Res 2021;31:365&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A. et al. Post-COVID-19 tachycardia syndrome: A distinct phenotype of post-acute COVID-19 syndrome. Am J Med 2021;134:1451&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ.. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020;100:327&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS. et al. Mast cell activation symptoms are prevalent in long-COVID. Int J Infect Dis 2021;112:217&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS. et al. Multisystem involvement in post&#x2010;acute sequelae of COVID&#x2010;19 (PASC). Ann Neurol 2021;91:367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G, Ricci F, Recce V. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: What do we know? J Cardiovasc Dev Dis 2021;8:156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP. et al. Autonomic dysfunction following COVID-19 infection: An early experience. Clin Auton Res 2021;31:385&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ.. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;A systemic review and comparison of clinical presentation and symptomatology. Medicina 2021;57:418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E. et al. Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;Evidence for an autoimmune disease. Autoimmun Rev 2018;17:601&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C.. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med 2021;19:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI.. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of post-acute COVID-19 syndrome. Trends Mol Med 2021;27:895&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschenberger M, Hunszinger V, Sparrer KMJ.. Implications of innate immunity in post-acute sequelae of non-persistent viral infections. Cells 2021;10:2134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="pubmed">34440903</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T. et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin Infect Dis Official Publ Infect Dis Soc Am 2021;74:ciab611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>World Physiotherapy. Safe rehabilitation approaches for people living with long COVID: Physical activity and exercise. World Physiotherapy Response to COVID-19 Briefing Paper 9. London, UK: World Physiotherapy, 2021.</Citation></Reference><Reference><Citation>Clavario P, Marzo VD, Lotti R. et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol 2021;340:113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302817</ArticleId><ArticleId IdType="pubmed">34311011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A, Dannerbeck L, Lange TJ. et al. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidiscip Resp Med 2021;16:732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893311</ArticleId><ArticleId IdType="pubmed">33623700</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J, Balagny P, Arnoult F. et al. Hyperventilation: A possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front Physiol 2021;11:614590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM. et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. eClinicalMedicine 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo RF, Mondoni M, Parazzini EM. et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J 2021;58:2100870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM. et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest 2021;161:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y, Lichter Y, Sadon S. et al. Cardiorespiratory abnormalities in patients recovering from COVID-19. J Am Soc Echocardiogr 2021;34:1273&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425293</ArticleId><ArticleId IdType="pubmed">34508837</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, Petrache I, Goldstein NM. et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Resp Crit Care 2021;205:126&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba GA, Ziehr DR, Rouvina JN. et al. Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. eClinicalMedicine 2021;39:101066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401400</ArticleId><ArticleId IdType="pubmed">34476393</ArticleId></ArticleIdList></Reference><Reference><Citation>Skj&#xf8;rten I, Ankerstjerne OAW, Trebinjac D. et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J 2021;58:2100996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL. et al. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci 2021;118:e2024358118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha DS, Love R.. Long COVID patient symptoms and its evaluation and management. J Nepal Med Assoc 2021;59:823&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107834</ArticleId><ArticleId IdType="pubmed">34508486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB. et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep 2021;11:13153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V. et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study. J Infect 2021. 10.1016/j.jinf.2021.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.036</ArticleId><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA. et al. Long COVID risk&#x2014;a signal to address sex hormones and women&#x2019;s health. Lancet Regional Heal 2021;11:100242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2021;373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallis TJM, Heiden E, Horno J. et al. Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19. Respir Res 2021;22:157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139368</ArticleId><ArticleId IdType="pubmed">34020644</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V, Cuadrado ML. et al. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case&#x2013;control study. Cephalalgia 2021;41:1332&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Pellicer-Valero OJ, Navarro-Pardo E. et al. The number of symptoms at the acute COVID-19 phase is associated with anxiety and depressive long-term post-COVID symptoms: A multicenter study. J Psychosom Res 2021;150:110625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455234</ArticleId><ArticleId IdType="pubmed">34563747</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteo T, Angelo C, Ilaria M. et al. Prevalence and predictors of persistence of COVID-19 symptoms in older adults: A single-center study. J Am Med Dir Assoc 2021. 10.1016/j.jamda.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8286874</ArticleId><ArticleId IdType="pubmed">34352201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q. et al. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol 2021;12:686029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Guizani I, Fourti N, Zidi W. et al. SARS-CoV-2 and pathological matrix remodeling mediators. Inflamm Res 2021;70:847&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294315</ArticleId><ArticleId IdType="pubmed">34286362</ArticleId></ArticleIdList></Reference><Reference><Citation>Desimmie BA, Raru YY, Awadh HM. et al. Insights into SARS-CoV-2 persistence and its relevance. Viruses 2021;13:1025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228265</ArticleId><ArticleId IdType="pubmed">34072390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, Iafrate F, Masci GM. et al. Chest CT score in COVID-19 patients: Correlation with disease severity and short-term prognosis. Eur Radiol 2020;30:6808&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334627</ArticleId><ArticleId IdType="pubmed">32623505</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z, Tang N, Chen Y. et al. CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatment. Sci Rep 2020;10:11548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360570</ArticleId><ArticleId IdType="pubmed">32665633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazdyrev E, Rusina P, Panova M. et al. Lung fibrosis after COVID-19: Treatment prospects. Pharm aceuticals2021;14:807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcis G, Bouquegneau A, Maes N. et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: A monocentric prospective observational cohort study. Int J Infect Dis 2021;109:209&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="pubmed">34273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A, Mahsouli A, Liistro G. et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Resp Med 2021;181:106383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Chen M, Collier GJ. et al. Hyperpolarized 129Xe MRI abnormalities in dyspneic participants 3 months after COVID-19 pneumonia: Preliminary results. Radiology 2021;301:210033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A. et al. Cardiopulmonary recovery after COVID-19: An observational prospective multicentre trial. Eur Respir J 2021;57:2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez DC, Normand K, Zhaoyun Y. et al. Long-term impact of COVID-19: A systematic review of the literature and meta-analysis. Biomedicines 2021;9:900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C. et al. Serum metabolic profile in patients with long-Covid (PASC) syndrome: Clinical implications. Front Med 2021;8:714426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesuthasan A, Massey F, Manji H. et al. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19. J Neurol Sci 2021;428:117608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8332920</ArticleId><ArticleId IdType="pubmed">34391037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH.. Cytokine storm. New Engl J Med 2020;383:2255&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R, Barreiro-Perez M, Martin-Garcia A. et al. Pericarditis and myocarditis long after SARS-CoV-2 infection: A cross-sectional descriptive study in health-care workers. Medrxiv2020:2020.07.12.20151316.</Citation></Reference><Reference><Citation>Singer ME, Taub IB, Kaelber DC. Risk of myocarditis from COVID-19 infection in people under age 20: A population-based analysis. Medrxiv2022:2021.07.23.21260998.</Citation></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT. et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection. JAMA Cardiol 2021;6:1078&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong S-W, Young BE. et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife 2021;10:e64909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury ATMM, Karim MR, Ali MdA. et al. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients&#x2014;A prospective multicenter cross-sectional study. Front Med 2021;8:663670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Nasr MB, D&#x2019;Addio F. et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 2021;3:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L. et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep 2021;36:109518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Lemos MP. et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. Biorxiv2021:2021.05.26.442666.</Citation></Reference><Reference><Citation>Zhou M, Yin Z, Xu J. et al. Inflammatory profiles and clinical features of COVID-19 survivors three months after discharge in Wuhan, China. J Infect Dis 2021;224:jiab181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083630</ArticleId><ArticleId IdType="pubmed">33822106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ. et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells 2021;10:386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF. et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis 2021;224:jiab490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L. et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022;3:100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022;23:210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert O, Begun L, Garren P. et al. Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines&#x2014;two case reports. Brain Behav Immun Health 2020;9:100173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606074</ArticleId><ArticleId IdType="pubmed">33163979</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorkiewicz P, Waszkiewicz N.. Biomarkers of post-COVID depression. J Clin Med 2021;10:4142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470902</ArticleId><ArticleId IdType="pubmed">34575258</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninx BWJH. Psychiatric symptoms and cognitive impairment in &#x201c;long COVID&#x201d;: The relevance of immunopsychiatry. World Psychiatry 2021;20:357&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8429338</ArticleId><ArticleId IdType="pubmed">34505378</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V, Pariante CM.. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf Open Immunol 2021;2:iqab004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928677</ArticleId><ArticleId IdType="pubmed">34192271</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, B&#xfc;ttiker P, Weissenberger S. et al. Editorial: The pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: A hypothesis. Med Sci Monitor 2021;27:e933015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P. et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging 2021;48:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G. et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 2021;144:awab009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M. et al. Long COVID hallmarks on [18F]FDG-PET/CT: A case&#x2013;control study. Eur J Nucl Med Mol Imaging 2021;48:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K. et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA 2016;113:E5472&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra I, Molino A. et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: A case&#x2013;control study. Biomedicines 2021;9:957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang J, Schiavon CR. et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res 2021;128:1323&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG. et al. &#x201c;LONG COVID&#x201d;&#x2014;A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect 2022;10:e00911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Salazar B, Holwerda M, St&#xfc;dle C. et al. COVID-19 and the vasculature: Current aspects and long-term consequences. Front Cell Dev Biol 2022;10:824851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H. et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost 2021;19:2546&#x2013;2553. 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Mei F, Bai L. et al. Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications? Free Radical Biol Med 2021;175:216&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404395</ArticleId><ArticleId IdType="pubmed">34474106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Renteria H, Travieso A, Sagir A. et al. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int J Cardiol 2021;345:153&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8542397</ArticleId><ArticleId IdType="pubmed">34706286</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandadeva D, Young BE, Stephens BY. et al. Blunted peripheral but not cerebral vasodilator function in young otherwise healthy adults with persistent symptoms following COVID-19. Am J Physiol Heart C 2021;321:H479&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384473</ArticleId><ArticleId IdType="pubmed">34296966</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Amor HIH, Jdidi J. et al. Long COVID 19 syndrome: Is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med 2021;8:745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE. et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. BMJ 2021;76:396&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C. et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C-S, Qi H-Y, Boularan C. et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol 2014;193:3080&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4179872</ArticleId><ArticleId IdType="pubmed">25135833</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE. et al. Investigation of long COVID prevalence and its relationship to Epstein&#x2013;Barr virus reactivation. Pathogens 2021;10:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 2022;71:226&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 2021;591:639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans LJ, Khan M, Yoo S-J. et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir Med 2021;9:e78&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Stallmach A, Pletz MW. et al. Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia 2021;35:920&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893131</ArticleId><ArticleId IdType="pubmed">33608636</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D. et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev 2021;20:102792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 2021;595:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter AG, Shields AM, Karim A. et al. Establishing the prevalence of common tissue&#x2010;specific autoantibodies following SARS-CoV&#x2010;2 infection. Clin Exp Immunol 2021;205:99&#x2013;105. 10.1111/cei.13623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13623</ArticleId><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K. et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 2021;4:100100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P. et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin Med 2021;21:e63&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C. et al. Case report: Neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med 2021;8:754667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota HR, Nune A.. Long COVID from rheumatology perspective&#x2014;a narrative review. Clin Rheumatol 2021;41:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi E, Bagherpour Z, Zarei E. et al. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function. Pathol Res Pract 2022;231:153782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8800420</ArticleId><ArticleId IdType="pubmed">35121363</ArticleId></ArticleIdList></Reference><Reference><Citation>Codd AS, Hanna SJ, Compeer EB. et al. Neutrophilia, lymphopenia and myeloid dysfunction: A living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxf Open Immunol 2021;2:iqab016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371938</ArticleId><ArticleId IdType="pubmed">35593707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna SJ, Codd AS, Gea-Mallorqui E. et al. T cell phenotypes in COVID-19. Oxf Open Immunol 2020;2:iqaa007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798577</ArticleId><ArticleId IdType="pubmed">33575657</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Dzieciatkowska M. et al. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J Proteome Res 2020;19:4455&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640979</ArticleId><ArticleId IdType="pubmed">33103907</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A, Tellone E, Barreca D. et al. Implication of COVID-19 on erythrocytes functionality: Red blood cell biochemical implications and morpho-functional aspects. Int J Mol Sci 2022;23:2171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8878454</ArticleId><ArticleId IdType="pubmed">35216286</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ning D, Kuebler WM, Bloch W.. The oxygen dissociation curve of blood in COVID-19. Am J Physiol 2021;321:L349&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384474</ArticleId><ArticleId IdType="pubmed">33978488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M, Hohberger B, Hoffmanns J. et al. Physical phenotype of blood cells is altered in COVID-19. Biophys J 2021;120:2838&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Misiti F. SARS-CoV-2 infection and red blood cells: Implications for long term symptoms during exercise. Sports Med Health Sci 2021;3:181&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302835</ArticleId><ArticleId IdType="pubmed">34337552</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregorova M, Morse D, Brignoli T. et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. eLife 2020;9:e63430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7775105</ArticleId><ArticleId IdType="pubmed">33331820</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V. et al. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J Invest Med 2022;70:61&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres&#x2010;Ruiz J, Lomel&#xed;n&#x2010;Gasc&#xf3;n J, Lira&#x2010;Luna J. et al. FANSY POSTCOV: A composite clinical immunological predictive index for post&#x2010;COVID&#x2010;19 syndrome unveils distinctive features in a cohort study of mild to critical patients. Clin Transl Med 2021;11:e623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611773</ArticleId><ArticleId IdType="pubmed">34841707</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: A cross&#x2010;sectional evaluation. J Med Virol 2021;93:1013&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Stam H, Stucki G, Bickenbach J.. Covid-19 and post intensive care syndrome: A call for action. J Rehabil Med 2020;52:jrm00044.</Citation><ArticleIdList><ArticleId IdType="pubmed">32286675</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D, Larsson L, Bergquist J.. Hypothesis: Mechanisms that prevent recovery in prolonged ICU patients also underlie myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front Med 2021;8:628029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876311</ArticleId><ArticleId IdType="pubmed">33585528</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S. et al. The conundrum of &#x2018;Long-COVID-19&#x2019;: A narrative review. Int J Gen Med 2021;14:2491&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeco A, Marotta N, Barletta M. et al. Rehabilitation of patients post-COVID-19 infection: A literature review. J Int Med Res 2020;48:0300060520948382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450453</ArticleId><ArticleId IdType="pubmed">32840156</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ler T, Yurdakul FG, Sivas FA. et al. Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes. Rheumatol Int 2021;41:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34580754</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavrou VT, Tourlakopoulos KN, Vavougios GD. et al. Eight weeks unsupervised pulmonary rehabilitation in previously hospitalized of SARS-CoV-2 infection. J Personal Med 2021;11:806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8399744</ArticleId><ArticleId IdType="pubmed">34442450</ArticleId></ArticleIdList></Reference><Reference><Citation>Udina C, Ars J, Morandi A. et al. Rehabilitation in adult post-COVID-19 patients in post-acute care with therapeutic exercise. J Frailty Aging 2021;10:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876526</ArticleId><ArticleId IdType="pubmed">34105716</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O&#x2019;Brien KK.. Conceptualising long COVID as an episodic health condition. BMJ Glob Health 2021;6:e007004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G. et al. Symptoms, complications and management of long COVID: A review. J R Soc Med 2021;114:428&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J. et al. Long covid&#x2014;mechanisms, risk factors, and management. BMJ 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke-Chambour M, Bridevaux P-O, Clarenbach CF. et al. Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Respiration 2021;100:826&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339046</ArticleId><ArticleId IdType="pubmed">34091456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, Leitl D, Jarosch I. et al. Benefits of pulmonary rehabilitation in COVID-19&#x2014;a prospective observational cohort study. ERJ Open Res 2021;31:00108&#x2013;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance H, Maslach A, Stoneman E. et al. Addressing post-COVID symptoms: A guide for primary care physicians. J Am Board Fam Med 2021;34:1229&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">34772779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C, Sturm C, Loudovici-Krug D. et al. The impact of post-COVID-syndrome on functioning&#x2014;Results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol 2021;16:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495185</ArticleId><ArticleId IdType="pubmed">34620202</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker FL, Smith KA, Z&#xfa;&#xf1;iga TM. et al. Acute exercise increases immune responses to SARS CoV-2 in a previously infected man. Brain Behav Immun Health 2021;18:100343&#x2013;100343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423674</ArticleId><ArticleId IdType="pubmed">34514439</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman D, Vishnubala D, Feuvre PL. et al. Returning to physical activity after covid-19. BMJ 2021;372:m4721.</Citation><ArticleIdList><ArticleId IdType="pubmed">33419740</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF. et al. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 2022;43:1157&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow AK, Malone LA, Kokorelis C. et al. Long-term COVID 19 sequelae in adolescents: The overlap with orthostatic intolerance and ME/CFS. Curr Pediatr Rep 2022;10:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906524</ArticleId><ArticleId IdType="pubmed">35287333</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J. et al. Multi&#x2010;disciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection (PASC) patients. PM&amp;R 2021;13:1027&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;cary S, Gaboury I, Poirier S. et al. Humility and acceptance: Working within our limits with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. J Orthop Sports Phys 2021;51:197&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">33930983</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>